Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9

Topic: Genetics and APOE

The bacterial CRISPR/Cas9 system allows sequence-specific gene editing in many organisms and holds promise as a tool to generate models of human diseases, for example, in human pluripotent stem cells. CRISPR/Cas9 introduces targeted double-stranded breaks (DSBs) with high efficiency, which are typically repaired by non-homologous end-joining (NHEJ) resulting in nonspecific insertions, deletions or other mutations (indels). DSBs may also be repaired by homology-directed repair (HDR) using a DNA repair template, such as an introduced single-stranded oligo DNA nucleotide (ssODN), allowing knock-in of specific mutations. Although CRISPR/Cas9 is used extensively to engineer gene knockouts through NHEJ, editing by HDR remains inefficient and can be corrupted by additional indels, preventing its widespread use for modelling genetic disorders through introducing disease-associated mutations. Furthermore, targeted mutational knock-in at single alleles to model diseases caused by heterozygous mutations has not been reported. Here we describe a CRISPR/Cas9-based genome-editing framework that allows selective introduction of mono- and bi-allelic sequence changes with high efficiency and accuracy. We show that HDR accuracy is increased dramatically by incorporating silent CRISPR/Cas-blocking mutations along with pathogenic mutations, and establish a method termed 'CORRECT' for scarless genome editing. By characterizing and exploiting a stereotyped inverse relationship between a mutation's incorporation rate and its distance to the DSB, we achieve predictable control of zygosity. Homozygous introduction requires a guide RNA targeting close to the intended mutation, whereas heterozygous introduction can be accomplished by distance-dependent suboptimal mutation incorporation or by use of mixed repair templates. Using this approach, we generated human induced pluripotent stem cells with heterozygous and homozygous dominant early onset Alzheimer's disease-causing mutations in amyloid precursor protein (APP(Swe)) and presenilin 1 (PSEN1(M146V)) and derived cortical neurons, which displayed genotype-dependent disease-associated phenotypes. Our findings enable efficient introduction of specific sequence changes with CRISPR/Cas9, facilitating study of human disease.

@article{paquet2016-27120160,
  author  = {Paquet, D. and Kwart, D. and Chen, A. and Sproul, A. and Jacob, S. and Teo, S. and Olsen, K. M. and Gregg, A. and others},
  title   = {{Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9}},
  journal = {Nature},
  year    = {2016},
  doi     = {10.1038/nature17664},
  pmid    = {27120160},
  url     = {https://doi.org/10.1038/nature17664}
}

Key findings

• Our findings enable efficient introduction of specific sequence changes with CRISPR/Cas9, facilitating study of human disease.

New to this subject? Start with our plain-English guide: Genetics →

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1038/nature17664
• PubMed: 27120160
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Related studies in Risk genes beyond APOE

• Contribution of homozygous and compound heterozygous missense mutations in VWA2 to Alzheimer's disease Neurobiology of aging · 2020-09-12 · usefulness score 55/100
• CRISPR–Cas9–Mediated Genetic Correction for Alzheimer's Disease A Hypothetical Therapeutic Framework Zenodo (CERN European Organization for Nuclear Research) · 2025-12-23 · usefulness score 39/100
• Crispr/cas9 como alternativa terapêutica para pacientes com doença de Alzheimer: uma revisão integrativa Revista Neurociências · 2026-01-30 · usefulness score 28/100
• Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease Nature medicine · 2002-10-15 · usefulness score 63/100
• TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers Molecular neurodegeneration · 2019-05-08 · usefulness score 53/100
• Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function Molecular neurodegeneration · 2011-10-07 · usefulness score 45/100

Also tagged “autophagy”

240 studies in the library carry the topic tag “autophagy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 240 tagged studies.

• An astrocyte-neuron HSPB1 axis preserves lysosomal integrity and protects from tau pathology Research Square · 2026-10-12 · usefulness score 16/100 · Disease mechanisms
• Chaperone-mediated autophagy: a gatekeeper of neuronal proteostasis Autophagy · 2021-06-10 · usefulness score 41/100 · Disease mechanisms
• Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases Neurobiology of aging · 2005-03-01 · usefulness score 36/100 · Down syndrome and Alzheimer's

Similar studies

• CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease PSEN 1 M146L mutation 2022 · Biomarkers
• CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer's PSEN2 N141I neurons 2017 · Biomarkers
• A genetically modified minipig model for Alzheimer's disease with SORL1 haploinsufficiency 2022 · Risk genes beyond APOE
• CRISPR/dCas9-Dnmt3a-mediated targeted DNA methylation of APP rescues brain pathology in a mouse model of Alzheimer's disease 2022 · Biomarkers
• Current Clinical Applications of In Vivo Gene Therapy with AAVs 2021 · Brain scans and imaging
• A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ 2019 · Genetics

More on Risk genes beyond APOE

• A review that covers this ground Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models Frontiers in genetics · 2014-04-23 · usefulness score 40/100
• Newest in this subject Pregnancy History and Loss of Normal PSEN2 Function Impact Female Late-Life Cognitive Processing, Inhibitory Signaling, and Gliosis bioRxiv · 2026-10-30 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Temporal Proteomics Links the APP London Mutation to Early Cholesterol Remodeling Cell Programs in Human Neurons bioRxiv · 2026-10-24 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Risk genes beyond APOE →